{"transactions":[{"id":1591561,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T00:40:45.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":15456,"price":3.44,"value":53168.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":531553,"source":{"system":"sec-edgar","filing":"0001062993-24-005759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005759/form4.xml","form_type":"4"}},{"id":1591560,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T00:40:45.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":147790,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":547009,"source":{"system":"sec-edgar","filing":"0001062993-24-005759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005759/form4.xml","form_type":"4"}},{"id":1682175,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-09T21:48:42.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":185400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Standard BioTools Inc., a Delaware corporation (\"Parent\"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the \"Merger\"); and"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the \"Exchange Ratio\") of the Parent's common stock, par value $0.001 (the \"Parent Common Stock\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-24-001326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837412/000120919124001326/doc4.xml","form_type":"4"}},{"id":1847769,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-21T21:32:56.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":false,"shares":134961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":447868,"derivative":{"exercise_price":7.3,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":134961},"source":{"system":"sec-edgar","filing":"0001062993-23-013930","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013930/form4.xml","form_type":"4"}},{"id":1847768,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:56.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":64961,"price":8.14,"value":528782.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.00 to $8.34, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":399219,"source":{"system":"sec-edgar","filing":"0001062993-23-013930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013930/form4.xml","form_type":"4"}},{"id":1847767,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:56.000Z","date":"2023-06-20","kind":"sale","planned":true,"acquired":false,"shares":70000,"price":8.14,"value":569800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.00 to $8.34, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":464180,"source":{"system":"sec-edgar","filing":"0001062993-23-013930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013930/form4.xml","form_type":"4"}},{"id":1847766,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-21T21:32:56.000Z","date":"2023-06-20","kind":"exercise","planned":true,"acquired":true,"shares":134961,"price":7.3,"value":985215.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."}],"balance_after":534180,"source":{"system":"sec-edgar","filing":"0001062993-23-013930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013930/form4.xml","form_type":"4"}},{"id":1849459,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T21:41:05.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":false,"shares":14328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":582829,"derivative":{"exercise_price":7.3,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":14328},"source":{"system":"sec-edgar","filing":"0001062993-23-013872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013872/form4.xml","form_type":"4"}},{"id":1849458,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-20T21:41:05.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":14328,"price":8.53,"value":122217.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to $8.72, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":399219,"source":{"system":"sec-edgar","filing":"0001062993-23-013872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013872/form4.xml","form_type":"4"}},{"id":1849457,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-20T21:41:05.000Z","date":"2023-06-15","kind":"exercise","planned":true,"acquired":true,"shares":14328,"price":7.3,"value":104594.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."}],"balance_after":413547,"source":{"system":"sec-edgar","filing":"0001062993-23-013872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013872/form4.xml","form_type":"4"}},{"id":1849456,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-20T21:41:05.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":55672,"price":8.53,"value":474882.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to $8.72, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":399219,"source":{"system":"sec-edgar","filing":"0001062993-23-013872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013872/form4.xml","form_type":"4"}},{"id":1855395,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-14T16:52:10.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":185400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":185400,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-23-037071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1837412/000120919123037071/doc4.xml","form_type":"4"}},{"id":1865127,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-06T20:23:27.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":38000,"price":7.16,"value":272080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":454891,"source":{"system":"sec-edgar","filing":"0001062993-23-013030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323013030/form4.xml","form_type":"4"}},{"id":1963183,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:03:04.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":177377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":177377,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":177377},"source":{"system":"sec-edgar","filing":"0001062993-23-006326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006326/form4.xml","form_type":"4"}},{"id":1963182,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-09T01:03:04.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":118203,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":492891,"source":{"system":"sec-edgar","filing":"0001062993-23-006326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006326/form4.xml","form_type":"4"}},{"id":2244560,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T23:00:14.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":597157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":597157,"derivative":{"exercise_price":7.3,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":597157},"source":{"system":"sec-edgar","filing":"0001209191-22-034343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122034343/doc4.xml","form_type":"4"}},{"id":2244559,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":93418,"kind":"person","name":"PETERSON TYCHO","position":1,"cik":"0001927856","reported_name":"PETERSON TYCHO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-03T23:00:14.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":374688,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374688,"source":{"system":"sec-edgar","filing":"0001209191-22-034343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122034343/doc4.xml","form_type":"4"}}]}